Navigation Links
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 24, 2008
Date:4/10/2008

WALTHAM, Mass., April 10 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO) announced that it will release its financial results for the first quarter of 2008 before the market opens on Thursday, April 24, 2008, and will hold a conference call on the same day at 9:00 a.m. Eastern Time.

During the call, the company will discuss its first quarter financial performance as well as future expectations. To listen, call (866) 793-1301 within the U.S. or (703) 639-1307 outside the U.S. and use conference ID 1212657. Please begin dialing at least 10 minutes before the scheduled starting time. You may also listen to the call live on our Website, http://www.thermofisher.com, by clicking on "Investors." The earnings press release and related information will be in the Investors section under "Quarterly Results." An audio archive of the call will be available in the "Webcasts and Presentations" section through Friday, May 23, 2008.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Thermo Fisher Scientific Unveils New Laboratory Technologies at Analytica 2008
2. Boston College, MIT researchers achieve dramatic increase in thermoelectric efficiency
3. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
4. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
5. Thermo Fisher Scientific to Webcast Press Conference at PITTCON 2008
6. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
7. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
8. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
9. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2008)...RNewswire-USNewswire/ -- MedImmune announced today...ademy of Pediatrics (AAP),2008 National Conference...dy of research into the prevention of respiratory ...spiratory infection among preterm infants., "As w... RSV disease on,preterm babies, the benefits of pr...
(Date:10/10/2008)...., Oct. 10 /- Neurobiologic...oday announced it will hold a,conference call on M...rinex(TM) (ancrod) Phase 3 Trial Program for acute... Freiman, president and chief executive,officer an...-- Date: Monday, October 13, 2008 -- Time: 1:00 ...
(Date:10/10/2008)...exas, Oct. 10 /- CSMG,Techn...ology management,company, announced the company ha...approval is on a key divisional application for "B...Frequency Electric Current,Therethrough" for CSMG ..."),platform tissue bonding/welding technology. The...
(Date:10/10/2008)...f., Oct. 10 /- Finesse Solutions, LLC...ons for life science process,applications, is plea...tore,that makes shopping for sensors and transmitt...inesse web site ( http://www.finesse.com/shopfines... sensors and accessories,on-line, anywhere in the ...
Breaking Biology Technology:MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3
...bout the latest outrages in the CEO suite, let me ...jority of top executives are honest and good peopl... success. And that the CEO,s I will be talking abo...g. Still, these are people who work the system to ... that can easily lead even the most successful com...
... promote competition. It was supposed to create ce... better infrastructure. Ten years later, can we sa...s wasted? Did we ever really achieve the open comp...esday is the tenth anniversary of the act. Especia... these controversies surrounding competition and t...
...d Software, a Milwaukee-based startup that runs an...eships around the universe. , , Official screensh...Technology Innovation Center that houses many more...s like Shining Brow Software and Niceware Inter...t Vendetta Online , came about in part because of...
...ank of Green Bay have joined a new $125 venture fu..., Tonka Bay Equity Partners of Minnetonka, Minnes...s from around the country and some individual inve...sinesses in manufacturing and business services. ,...roughout Wisconsin, but they,re particularly focus...
Other Biology Technology:What color is your CEO's parachute? 2What color is your CEO's parachute? 3What color is your CEO's parachute? 4Was the Telecom Act of 1996 a boon or bomb for U.S.? 2Was the Telecom Act of 1996 a boon or bomb for U.S.? 3Was the Telecom Act of 1996 a boon or bomb for U.S.? 4Was the Telecom Act of 1996 a boon or bomb for U.S.? 5John Bergman, co-founder of Guild Software 2John Bergman, co-founder of Guild Software 3
(Date:10/12/2008)...elease is also available in French . , Resear...and GlaxoSmithKline Inc. have identified two genet... astounding sevenfold increase the risk of male pa...t. 12 in the journal Nature Genetics. , About ...ldness by age 45. The condition,s social and econo...
(Date:10/12/2008)...ave a built-in weapon against HIV, but until recen... study published online by the journal Nature re...me known as APOBEC-3G and suggests new directions... every human cell. It is capable of stopping HIV a...us transcribes its RNA into viral DNA. , The stu...
(Date:10/10/2008)... for Special Surgery researchers have found that s...n who are suffering from pregnancy complications c...g to a study in mice. In this autoimmune syndrome,...ipids, the main components of cell membranes. This...issue of the Journal of Clinical Investigation t...
(Date:10/10/2008)...chers report on a previously unknown relationship ...f their mitochondria a cell,s energy makers. Stem ...eater capacity to differentiate and are more likel...his week in JBC, could lead to methods of enrichin...eutic use and may provide some insights into the r...
Breaking Biology News(10 mins):Researchers discover baldness gene: 1 in 7 men at risk 2Body's anti-HIV drug explained 2Statins may prevent miscarriages 2Statins may prevent miscarriages 3Toms of Maine Tooth Floss Earns American Dental Associations Seal of Acceptance 1187 1Toms of Maine Tooth Floss Earns American Dental Associations Seal of Acceptance 1187 2J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 1J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 2J D Power and Associates Reports 3A CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year 1184 3Verdict One Releases Directory of Board Certified Attorneys for Consumers 1181 1Verdict One Releases Directory of Board Certified Attorneys for Consumers 1181 2Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 1Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 2Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion P 562 3
...nsion in yeast have been identified by researchers...ically reducing calorie intake, or caloric restric...ncluding yeast, worms and rodents. Previous resear...on due to caloric restriction, but worms and yeast...gh diet, showing that some other genes must be at ...
...s nerve cells to trees -- some are short and bushy...ew branches coming out of one or two main trunks. ...ic disorders and Firestein,s quest is to discover ..., A new paper by Firestein and her colleagues at R...es the role of the protein snapin in nerve branch,...
...have found that gene expression in the brain can d...h different life histories. Their study indicates ...how differential expression in males who migrate f...ns versus those who do not leave the freshwater en... University, the University of Massachusetts and t...
...e biological trigger that gives rise to Van Buchem...that can cause blindness and deafness. The finding...and could lead to new treatments for osteoporosis ...eam from Lawrence Livermore and Lawrence Berkeley ... BioMedical Research in Switzerland, and the DOE J...
Other Biology News:Snapin: A protein with therapy potential for autism 2Divergent life history shapes gene expression in brains of salmon 2Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
...madzu Biotech presents PsiPort Mass Directed Auto ... data acquisition system designed for automated co...ence and pharmaceutical discovery programs. The sy...gh throughput mass directed auto purification for ...
The Rapid DNA Ligation Kit enables ligation of sticky-end or blunt-end DNA fragments in just 5 min at 15-25 C. Depending on the DNA concentration, either circular (low DNA concentration) or concatem
Nuclease S7; Micrococcal nuclease from Roche Applied Science
Anti-VDAC (Voltage-Dependent Anion Channel) AVOID FREEZE/THAW CYCLES. Recognizes the porin 31HL protein. Corresponds to mAb 1 in the literature.
Biology Products: